Head of Finance & Investor Relations (m/f/d)

• Cellbricks
• Berlin | On-site | Full-time | CFO track | Fluent English required
• About Cellbricks Therapeutics

At Cellbricks Therapeutics, we work towards a future where humans can enjoy longer and healthier lives.

Every 30 seconds, a patient dies from a disease caused by tissue dysfunction.

Our vision is to change that by producing bioengineered, implantable human tissue that restores organ and tissue function for millions of patients.

Our mission is backed by visionary investors, including ACT Ventures Partners, Silicon Round About Ventures and SPRIND – Federal Agency for Breakthrough Innovation, as well as key individual investors.

Cellbricks Therapeutics is a Berlin- and Boston-based biotech company developing bioengineered tissue therapeutics.

We combine bioprinting, tissue engineering and regenerative medicine to build functional human tissue at scale.

We are an interdisciplinary team of biotechnologists, engineers, chemists and entrepreneurs from more than 14 nations, united by a proactive, hands-on approach to solving hard scientific problems.

Our team is currently advancing multiple therapeutic programmes focused on the restoration of complex wounds and organ failure towards pre-IND and IND milestones, in collaboration with leading clinical, pharmaceutical and manufacturing partners.

Currently, we are preparing for our next major stage of development and Series-A financing.

About the Role

We are looking for a finance leader who will help build the financial backbone for that stage and play a central role in preparing and executing an ambitious international Series A with leading investors.

Work closely with our Co-CEOs, leadership team, fractional CFO and external finance specialists to progressively bring financial planning, controlling, reporting and investor relations further inside Cellbricks.

Translate scientific, operational and commercial plans into a credible financing story, ensuring readiness for investor due diligence and execution.

You will help establish the financial insight, systems and decision-making discipline required to scale Cellbricks successfully.

What You Will Do

• Finance & financial planning
• Budgeting, forecasting, liquidity planning & runway management.
• Integrated financial models, financing scenarios, use-of-funds planning & performance tracking.
• Coordination of accounting, payroll, tax, audit, grant reimbursement & external providers; continuous improvement of systems, controls & data quality.
• Series A, investor relations & board
• Financial preparation & execution of the international Series A, incl. investor materials, data-room readiness, transaction workstreams & the equity story.
• Investor reporting, shareholder communication, financial Q&A & trusted working relationships with investors.
• Board agendas, materials, financial presentations, management inputs & follow-up of decisions & commitments.
• Building the internal finance function
• Initially work alongside an experienced fractional CFO
  & external finance team, benefiting from proven processes & structured onboarding.
• Assume broader ownership over time & build a
  scalable in-house finance and investor-relations function, with a credible path toward Finance Director / VP Finance & potentially CFO responsibility.

What You Bring

• Meaningful hands-on ownership in a substantial institutional financing, ideally a successful Series A.
• Typically, 5+ years in finance, corporate finance, transaction advisory or investor relations.
• Strong modelling, budgeting & forecasting skills, plus a working understanding of German accounting, tax & corporate-finance fundamentals.
• Strategic and hands-on, with independent judgment, strong communication & credibility across management, investors & board.
• Fluent English; German highly desirable.
• Nice to Have
• Deep-tech or another R&D-intensive environment;
  ideally biotech, life sciences, medtech.
• International investors, particularly from Europe & US.
• International group structures, especially cross-border intercompany acc., financing or transfer-pricing involving German & US entities.
• Grant-funded R&D, non-dilutive financing, board reporting or internalizing a finance function

Why Join Cellbricks Therapeutics?

• Build a central role in building a deep-tech-rooted biotech company.
• Shape a defining role in the international Series A, with European and US investor exposure.
• Grow with structured support, meaningful stock options and a credible path to CFO.
• Have a real impact on the future of medicine through the development of bioengineered tissue therapeutics.
• Work with a fantastic, international and interdisciplinary team.

What We Offer

• Competitive salary and benefits, including Urban Sports, the Deutschlandticket and a €50 voucher.
• Stock options.
• 30 days of annual leave.
• Regular team events.
• Where You Will Work

This role is based in Berlin, Germany, within our management team.

#J-18808-Ljbffr